Literature DB >> 9141514

Tissue-specific expression of alpha and beta messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states.

M C Zennaro1, N Farman, J P Bonvalet, M Lombès.   

Abstract

Expression of the mineralocorticoid receptor (MR) is restricted to some sodium-transporting epithelia and a few nonepithelial target tissues. Determination of the genomic structure of the human MR (hMR) revealed two different untranslated exons (1alpha and 1beta), which splice alternatively into the common exon 2, giving rise to two hMR mRNA isoforms (hMR alpha and hMR beta). We have investigated expression of hMR transcripts in renal, cardiac, skin, and colonic tissue samples by in situ hybridization with exon 1alpha and 1beta specific riboprobes, using an exon 2 probe as internal control. Specific signals for either exon 1alpha- and 1beta-containing mRNAs were detected in typically hMR-expressing cells in all tissues analyzed. hMR alpha and hMR beta were present in distal tubules of the kidney, in cardiomyocytes, in enterocytes of the colonic mucosa, and in keratinocytes and sweat glands. Interestingly, although both isoforms appear to be expressed at approximately the same level, the relative abundance of each message compared with that of exon 2-containing mRNA strikingly differs among aldosterone target tissues, suggesting the possibility of other tissue-specific transcripts originating from alternative splicing. Finally, functional hypermineralocorticism was associated with reduced expression of hMR beta in sweat glands of two patients affected by Conn's and Liddle's syndrome, whereas normal levels of hMR isoforms were found in one case of pseudohypoaldosteronism. Altogether, our results indicate a differential, tissue-specific expression of hMR mRNA isoforms, hMR beta being down-regulated in situations of positive sodium balance, independently of aldosterone levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141514     DOI: 10.1210/jcem.82.5.3933

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  The N-terminal domain of the mineralocorticoid receptor modulates both mineralocorticoid receptor- and glucocorticoid receptor-mediated transactivation from Na/K ATPase beta1 target gene promoter.

Authors:  A Derfoul; N M Robertson; D J Hall; G Litwack
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  The size of a melanin-based plumage ornament correlates with glucocorticoid receptor concentrations in the skin of that ornament.

Authors:  Christine R Lattin; L Michael Romero
Journal:  Biol Lett       Date:  2013-09-11       Impact factor: 3.703

3.  Hormonal control of the metabolic machinery of hepatocellular carcinoma.

Authors:  Carmen Chak-Lui Wong; Chun-Ming Wong; Irene Oi-Lin Ng
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

Review 4.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 5.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

6.  Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action.

Authors:  M C Zennaro; D Le Menuet; S Viengchareun; F Walker; D Ricquier; M Lombès
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

7.  Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.

Authors:  S Berger; M Bleich; W Schmid; T J Cole; J Peters; H Watanabe; W Kriz; R Warth; R Greger; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis.

Authors:  Rongqin Ren; Robert H Oakley; Diana Cruz-Topete; John A Cidlowski
Journal:  Endocrinology       Date:  2012-09-18       Impact factor: 4.736

9.  Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates.

Authors:  Laetitia Martinerie; Say Viengchareun; Anne-Lise Delezoide; Francis Jaubert; Martine Sinico; Sophie Prevot; Pascal Boileau; Geri Meduri; Marc Lombès
Journal:  Endocrinology       Date:  2009-05-28       Impact factor: 4.736

10.  Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.

Authors:  Søren Ulrik Salling Sønder; Marianne Mikkelsen; Klaus Rieneck; Chris Juul Hedegaard; Klaus Bendtzen
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.